We only have this paper's title and publication details.
Read it at the sourceIntracerebral malignancyAnti-mitotic drug; modified viruses "growth factor responsive conditions
No takes yet. Share an insight, caveat, or question.
Roger A. Barker (2003) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: